Unprecedented Phase 1 CML efficacy data with 64% MMR achievement by 24 weeks in a refractory patient populationEncouraging safety and ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session ...

Terns Pharmaceuticals ( ($TERN) ) has shared an announcement. On November 3, 2025, Terns Pharmaceuticals announced that data from the Phase 1 ...

CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, ...

Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphomas showed encouraging preliminary efficacy data ...

Title: A dose-escalation and safety study of CID-103 followed by a randomized, open-label, parallel-arm multi-dose study ...

Q3 2025 Earnings Call November 3, 2025 8:30 AM ESTCompany ParticipantsJohn Kasel - President, CEO & DirectorWilliam Thalman ...

New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, from Week 12 to Week 28 regardless of prior advanced ...

If you're a small business looking to promote your sales the day after Black Friday, here's how you can easily use AI tools to design all your marketing assets for little to no money.

Benjamin Ball Associates, a London-based executive coaching and presentation training firm, has reported strengthened client feedback and announced refinements to its leadership and communication ...

Prezent, a startup that offers an AI-powered presentation builder to enterprises, said today that it has raised $30 million in funding led by Multiplier Capital, Greycroft, and Nomura Strategic ...